CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
4.165
-0.065 (-1.54%)
Nov 21, 2024, 4:00 PM EST - Market closed
CollPlant Biotechnologies Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | -17.47 | -7.02 | -16.93 | 0.24 | -5.77 | -11.16 | Upgrade
|
Depreciation & Amortization | 1.1 | 1.1 | 1.08 | 0.77 | 0.66 | 0.54 | Upgrade
|
Loss (Gain) From Sale of Assets | 0.02 | 0.02 | - | - | - | - | Upgrade
|
Stock-Based Compensation | 1.87 | 1.94 | 2.17 | 1.6 | 1.67 | 1.13 | Upgrade
|
Other Operating Activities | 0.14 | 0.35 | 0.52 | -0.32 | -0.1 | 3.17 | Upgrade
|
Change in Accounts Receivable | 9.91 | 0.01 | 0.26 | 0.56 | -0.75 | 0.44 | Upgrade
|
Change in Inventory | 1.18 | 0.75 | -0.31 | 0.18 | -0.37 | -0.07 | Upgrade
|
Change in Accounts Payable | 0.38 | -0.15 | 0.1 | 0.24 | -0.04 | 0.23 | Upgrade
|
Change in Unearned Revenue | - | - | -0.03 | -0.18 | -0.74 | -1.01 | Upgrade
|
Change in Other Net Operating Assets | 0.13 | 0.24 | -0.56 | -0.59 | 0.98 | 1.05 | Upgrade
|
Operating Cash Flow | -2.75 | -2.76 | -13.7 | 2.5 | -4.45 | -5.7 | Upgrade
|
Capital Expenditures | -0.76 | -0.95 | -1.27 | -1.43 | -0.44 | -1.49 | Upgrade
|
Sale of Property, Plant & Equipment | 0.07 | 0.07 | - | 0.03 | - | 0.03 | Upgrade
|
Sale (Purchase) of Intangibles | - | - | -0.04 | -0.16 | -0.08 | - | Upgrade
|
Investment in Securities | - | - | 30.24 | -30 | - | - | Upgrade
|
Other Investing Activities | -0.27 | -0.27 | - | - | - | - | Upgrade
|
Investing Cash Flow | -0.96 | -1.16 | 28.92 | -31.56 | -0.52 | -1.46 | Upgrade
|
Long-Term Debt Repaid | - | - | - | - | -0.02 | -0.02 | Upgrade
|
Net Debt Issued (Repaid) | - | - | - | - | -0.02 | -0.02 | Upgrade
|
Issuance of Common Stock | 0.23 | 1.11 | 1.87 | 38.76 | 4.54 | 5.45 | Upgrade
|
Other Financing Activities | - | - | - | - | -0.05 | -0.02 | Upgrade
|
Financing Cash Flow | 0.23 | 1.11 | 1.87 | 38.76 | 4.47 | 5.41 | Upgrade
|
Foreign Exchange Rate Adjustments | -0.18 | -0.38 | -0.61 | 0.14 | 0.06 | -0.06 | Upgrade
|
Net Cash Flow | -3.66 | -3.19 | 16.49 | 9.85 | -0.45 | -1.82 | Upgrade
|
Free Cash Flow | -3.51 | -3.72 | -14.97 | 1.07 | -4.89 | -7.19 | Upgrade
|
Free Cash Flow Margin | -508.85% | -33.92% | -5007.36% | 6.86% | -79.65% | -310.35% | Upgrade
|
Free Cash Flow Per Share | -0.31 | -0.33 | -1.36 | 0.09 | -0.71 | -1.44 | Upgrade
|
Cash Income Tax Paid | 0.01 | 0.01 | 0.03 | - | - | - | Upgrade
|
Levered Free Cash Flow | 2.13 | -1.9 | -8.9 | 0.94 | -2.82 | -3.27 | Upgrade
|
Unlevered Free Cash Flow | 2.13 | -1.9 | -8.89 | 0.95 | -2.81 | -3.26 | Upgrade
|
Change in Net Working Capital | -11.43 | -0.71 | 0.14 | -0.1 | 1.12 | -1.34 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.